BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 27, 2026, disclosing beneficial ownership of 914,372 shares of Anterix Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock reported beneficial ownership of 914,372 shares of Anterix Inc. common stock.
  • Percent of class: The 914,372 shares represent 4.7% of the outstanding class, as disclosed in the filing.
  • Sole voting power: BlackRock reported sole power to vote or direct the vote of 892,350 shares.
  • Sole dispositive power: BlackRock reported sole power to dispose or direct the disposition of 914,372 shares.
  • Shared voting and dispositive power: Both shared voting power and shared dispositive power are reported as 0.
  • Event date: The date of the event requiring this filing is stated as September 30, 2026.
  • Filer type: BlackRock, Inc. is identified as a parent holding company (type "HC"), organized in Delaware, with principal offices at 50 Hudson Yards, New York, NY 10001.

BlackRock's Amended Beneficial Ownership Position in Anterix Inc.

According to the filing, BlackRock, Inc. submitted Amendment No. 1 to its Schedule 13G disclosing a position in the common stock of Anterix Inc., whose principal executive offices are located at 3 Garret Mountain Plaza, Suite 401, Woodland Park, NJ 07424. The CUSIP number for the reported class of securities is 03676C100. The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc., on October 27, 2026.

The filing states that the Schedule 13G "reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the 'Reporting Business Units') of BlackRock, Inc. and its subsidiaries and affiliates." The filing further notes that it "does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units" in accordance with SEC Release No. 34-39538 (January 12, 1998).

With respect to dividend rights and sale proceeds, the filing discloses that "various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of Anterix Inc." and that "no one person's interest in the common stock of Anterix Inc. is more than five percent of the total outstanding common shares." The identity of the relevant BlackRock subsidiary is provided in Exhibit 99 attached to the filing. BlackRock certified that the securities were acquired and held in the ordinary course of business and not for the purpose of influencing control of the issuer.

What Was Disclosed

BlackRock, Inc. filed an amended Schedule 13G reporting 914,372 shares of Anterix Inc. common stock, equal to 4.7% of the class, with sole voting power over 892,350 shares and sole dispositive power over all 914,372 shares, as of September 30, 2026.